NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘RA Capital Management’

20 June 2014

Venture capital-backed Zafgen secures $96m via IPO

obb Venture capital-backed biopharmaceutical company Zafgen has raised $96m via its IPO on the Nasdaq exchange.

21 May 2014

KKR joins investors in biotherapeutics developer Coherus BioSciences

Coherus BioSciences, a US biologics platform company focused on biosimilars, has closed a Series C round raising $55m from investors including KKR, Venrock, RA Capital Management, Rock Springs Capital and Fidelity Biosciences.

22 April 2014

Vivo Capital leads $58.5m Series D for ProNAi Therapeutics

biotech_lrg Nucleic acid therapeutics developer ProNAi Therapeutics has secured $59.5m in a Series D round led by venture capital firm Vivo Capital.

4 December 2013

Biotech company Zafgen raises $45m Series E

biotech_lrg Biopharmaceutical business Zafgen has raised $45m in a Series E round to fund the development of its obesity therapeutic beloranib.

27 November 2012

Canadian drug company MethylGene seals C26.1m private placement

Toronto-listed drug development company MethylGene has raised C$26.1m through a private placement with participants including a number of private equity investors.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014